Piper Jaffray Cuts Pacific Biosciences (PACB) to Underweight Following Q2 Report
Tweet Send to a Friend
Piper Jaffray downgraded Pacific Biosciences of California (NASDAQ: PACB) from Neutral to Underweight Friday morning.
This article: 80 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 80 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
